SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 9th, 2021 • Ocugen, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 7, 2021, between Ocugen, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).